Skip to content

Amperozide

Drug profile

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Amperozide is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including FAAH and HTR6.

  • Molecular targets: FAAH and HTR6 (2 listed in DrugCentral).
  • Molecular formula: C23H29F2N3O; molecular weight 401.50 g/mol.

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Fatty-acid amide hydrolase 1FAAHunknownIC50 6.34
5-hydroxytryptamine receptor 6HTR6unknownKi 5.80

Chemical structure

Molecular formulaC23H29F2N3O
Molecular weight401.50 g/mol
CAS number75558-90-6
InChIKeyNNAIYOXJNVGUOM-UHFFFAOYSA-N
PubChem CID73333
CCNC(=O)N1CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Amperozide work?

Its molecular targets in DrugCentral include FAAH and HTR6.

What is the chemical formula of Amperozide?

Amperozide has the molecular formula C23H29F2N3O and a molecular weight of 401.50 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets2
Indications0
FormulaC23H29F2N3O
DrugCentral ID193
Interactive profile